Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide and Procarbazine in Recurrent/Progressive Gliomas
NCT00079092Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jan 2004
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in malignant glioma, sponsored by Wake Forest University Health Sciences. Started Jan 2004; status: completed.
02
Drugs
thalidomide
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT00079092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00079092.